Drug companies must provide “unbiased information” to patients, say MEPsBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c5511 (Published 05 October 2010) Cite this as: BMJ 2010;341:c5511
- Rory Watson
Governments would have to ensure that “objective, unbiased information” about prescription drugs is made available to the public under legislation now being drafted by the European parliament.
The information would have to include a summary of product characteristics, the labelling and package leaflet, and a publicly accessible version of the drug’s assessment report. The data would have to be available electronically on dedicated websites established by national authorities and in printed form.
The obligation was introduced into the draft legislation last week by the European parliament’s environment committee as part of moves to provide …
Log in using your username and password
Log in through your institution
Sign up for a free trial